Clinical Trials Logo

Clinical Trial Summary

Diabetic macular oedema (DMO) is a sight-threatening problem for diabetic patient who has swelling in macula. Patients with DMO can receive laser treatment and achieve good acuity finally. However, some patients still have difficulties in reading even after proper treatment.

In this project, the investigators aimed to explore the effectiveness of different training paradigms in improving reading performance in patients with DMO.


Clinical Trial Description

Patients with diabetic macular oedema (DMO), after receiving laser photocoagulation, achieved good outcomes in distance acuity. However, some patients, particularly those developing parafoveal scotoma, still had difficulty in reading. Inability to read or reading very slowly leads to the potential loss of job, as well as the enjoyment of reading for leisure.

In this study, the investigators aimed to investigate the effectiveness of reading rehabilitation using perceptual learning paradigms in enhancing reading performance in patients with reading difficulties due to DMO. Also, the fundamental mechanisms explaining the reading problems in patients with DMO reading Chinese will be examined.

The investigators hypothesize that the perceptual training would show an improvement in reading. The investigators' primary hypothesis is that temporal visual processing speed and spatial visual span will be improved after perceptual training. The investigators' secondary hypothesis is that the reading speed and fixation stability will be improved after training. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02457884
Study type Interventional
Source The Hong Kong Polytechnic University
Contact
Status Completed
Phase N/A
Start date May 2015
Completion date June 2018

See also
  Status Clinical Trial Phase
Completed NCT04576689 - Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy Phase 2
Completed NCT02554747 - Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa N/A
Withdrawn NCT02309476 - Sub-threshold Photocoagulation of Diabetic Macular Oedema N/A
Terminated NCT02207712 - Noctura400 Treatment for Diabetic Retinopathy (CANDLE) N/A
Completed NCT00148330 - Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study Phase 2/Phase 3
Completed NCT03495765 - To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus Phase 3
Completed NCT00167518 - Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO) Phase 2/Phase 3
Completed NCT01787669 - Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema Phase 2
Completed NCT01175070 - Intravitreal Macugen for Ischaemic Diabetic Macular Oedema Phase 4
Terminated NCT00427986 - Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema N/A
Completed NCT00333671 - Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema) N/A
Completed NCT02731911 - Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
Completed NCT00148265 - A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema Phase 2/Phase 3
Completed NCT02181400 - Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema N/A